tiprankstipranks
Trending News
More News >
AptarGroup (ATR)
NYSE:ATR
US Market

AptarGroup (ATR) Stock Forecast & Price Target

Compare
152 Followers
See the Price Targets and Ratings of:

ATR Analyst Ratings

Strong Buy
4Ratings
Strong Buy
3 Buy
1 Hold
0 Sell
Based on 4 analysts giving stock ratings to
AptarGroup
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

ATR Stock 12 Month Forecast

Average Price Target

$172.67
▲(12.63%Upside)
Based on 4 Wall Street analysts offering 12 month price targets for AptarGroup in the last 3 months. The average price target is $172.67 with a high forecast of $175.00 and a low forecast of $170.00. The average price target represents a 12.63% change from the last price of $153.31.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"120":"$120","134":"$134","148":"$148","162":"$162","176":"$176"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":175,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$175.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":172.67,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$172.67</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":170,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$170.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[120,134,148,162,176],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Mar<br/>2024","6":"Jul<br/>2024","9":"Jan<br/>2025","12":"May<br/>2025","25":"May<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,148.28,150.3353846153846,152.39076923076922,154.44615384615383,156.50153846153847,158.55692307692308,160.6123076923077,162.6676923076923,164.72307692307692,166.77846153846153,168.83384615384614,170.88923076923078,172.9446153846154,{"y":175,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,148.28,150.15615384615384,152.03230769230768,153.90846153846152,155.7846153846154,157.66076923076923,159.53692307692307,161.41307692307691,163.28923076923076,165.1653846153846,167.04153846153844,168.9176923076923,170.79384615384615,{"y":172.67,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,148.28,149.95076923076923,151.62153846153845,153.2923076923077,154.96307692307693,156.63384615384615,158.30461538461537,159.97538461538463,161.64615384615385,163.31692307692308,164.9876923076923,166.65846153846155,168.32923076923078,{"y":170,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":124.07,"date":1696118400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":121.09,"date":1704067200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":128.99,"date":1706745600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":138.67,"date":1709251200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":140.65,"date":1711929600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":146.41,"date":1717200000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":137.34,"date":1719792000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":152.34,"date":1725148800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":159.08,"date":1727740800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":156.65,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":156.7,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":149.1,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":148.28,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target$175.00Average Price Target$172.67Lowest Price Target$170.00
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
TipRanks Analyst forecast on ATR
TipRanks AITipRanks
Not Ranked
TipRanks
$165
Buy
7.63%
Upside
Reiterated
06/05/25
AptarGroup's stock score is driven by its strong financial performance and a positive earnings call outlook, despite some market challenges. Technical and valuation aspects are neutral, reflecting consolidation and moderate growth expectations.
Wells Fargo Analyst forecast on ATR
Gabrial HajdeWells Fargo
Wells Fargo
$162$170
Buy
10.89%
Upside
Reiterated
05/05/25
AptarGroup's Strong Pharmaceutical Growth and Strategic Initiatives Drive Buy Rating
William Blair Analyst forecast on ATR
Matt LarewWilliam Blair
William Blair
Buy
Reiterated
05/02/25
Analysts Offer Insights on Healthcare Companies: AptarGroup (NYSE: ATR) and Dexcom (NASDAQ: DXCM)
Bank of America Securities Analyst forecast on ATR
George StaphosBank of America Securities
Bank of America Securities
$173
Hold
12.84%
Upside
Reiterated
05/01/25
AptarGroup's Mixed Segment Performance and Economic Pressures Lead to Hold Rating
Raymond James Analyst forecast on ATR
Matt RobertsRaymond James
Raymond James
$190$175
Buy
14.15%
Upside
Reiterated
04/22/25
AptarGroup price target lowered to $175 from $190 at Raymond JamesAptarGroup price target lowered to $175 from $190 at Raymond James
DBS
$175
Buy
14.15%
Upside
Reiterated
02/24/25
AptarGroup's Strong Pharma Performance and Strategic Expansion Justify Buy RatingWe have a rating of BUY, with TP of USD$175. We have a rating of BUY, with TP of USD$175. Our TP is based on 30.5x 25F PE, 0.8 S.D. above its 5-year average. We believe its exceptional product technology can continue to drive revenues and share price.
Robert W. Baird Analyst forecast on ATR
Ghansham PanjabiRobert W. Baird
Robert W. Baird
$185$160
Buy
4.36%
Upside
Reiterated
02/10/25
AptarGroup price target lowered to $160 from $185 at BairdAptarGroup price target lowered to $160 from $185 at Baird
Jefferies Analyst forecast on ATR
Daniel RizzoJefferies
Jefferies
$205
Buy
33.72%
Upside
Reiterated
02/07/25
AptarGroup: Strong Q4 Performance and Promising Long-Term Outlook Support Buy RatingWe estimate an 8% increase in Pharma segment sales and think delivery systems for new products such as Neffy (recent FDA- and EU-approved epinephrine nasal spray), for GLP-1 drugs, and for OTC Narcan will add 100-200bps of Pharma segment volume growth. In Beauty, green shoots are emerging in China and demand likely trends higher in North America, but this will be partially offset by soft demand in Europe, particularly for high-end beauty products. In Closures, F&B demand likely churns higher, and margins expand with an improvement in mix and with improved cost absorption. The US$ is up ~5% against the €, ~5% against the £, ~3% against the Brazilian real since the last earnings call.
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
TipRanks Analyst forecast on ATR
TipRanks AITipRanks
Not Ranked
TipRanks
$165
Buy
7.63%
Upside
Reiterated
06/05/25
AptarGroup's stock score is driven by its strong financial performance and a positive earnings call outlook, despite some market challenges. Technical and valuation aspects are neutral, reflecting consolidation and moderate growth expectations.
Wells Fargo Analyst forecast on ATR
Gabrial HajdeWells Fargo
Wells Fargo
$162$170
Buy
10.89%
Upside
Reiterated
05/05/25
AptarGroup's Strong Pharmaceutical Growth and Strategic Initiatives Drive Buy Rating
William Blair Analyst forecast on ATR
Matt LarewWilliam Blair
William Blair
Buy
Reiterated
05/02/25
Analysts Offer Insights on Healthcare Companies: AptarGroup (NYSE: ATR) and Dexcom (NASDAQ: DXCM)
Bank of America Securities Analyst forecast on ATR
George StaphosBank of America Securities
Bank of America Securities
$173
Hold
12.84%
Upside
Reiterated
05/01/25
AptarGroup's Mixed Segment Performance and Economic Pressures Lead to Hold Rating
Raymond James Analyst forecast on ATR
Matt RobertsRaymond James
Raymond James
$190$175
Buy
14.15%
Upside
Reiterated
04/22/25
AptarGroup price target lowered to $175 from $190 at Raymond JamesAptarGroup price target lowered to $175 from $190 at Raymond James
DBS
$175
Buy
14.15%
Upside
Reiterated
02/24/25
AptarGroup's Strong Pharma Performance and Strategic Expansion Justify Buy RatingWe have a rating of BUY, with TP of USD$175. We have a rating of BUY, with TP of USD$175. Our TP is based on 30.5x 25F PE, 0.8 S.D. above its 5-year average. We believe its exceptional product technology can continue to drive revenues and share price.
Robert W. Baird Analyst forecast on ATR
Ghansham PanjabiRobert W. Baird
Robert W. Baird
$185$160
Buy
4.36%
Upside
Reiterated
02/10/25
AptarGroup price target lowered to $160 from $185 at BairdAptarGroup price target lowered to $160 from $185 at Baird
Jefferies Analyst forecast on ATR
Daniel RizzoJefferies
Jefferies
$205
Buy
33.72%
Upside
Reiterated
02/07/25
AptarGroup: Strong Q4 Performance and Promising Long-Term Outlook Support Buy RatingWe estimate an 8% increase in Pharma segment sales and think delivery systems for new products such as Neffy (recent FDA- and EU-approved epinephrine nasal spray), for GLP-1 drugs, and for OTC Narcan will add 100-200bps of Pharma segment volume growth. In Beauty, green shoots are emerging in China and demand likely trends higher in North America, but this will be partially offset by soft demand in Europe, particularly for high-end beauty products. In Closures, F&B demand likely churns higher, and margins expand with an improvement in mix and with improved cost absorption. The US$ is up ~5% against the €, ~5% against the £, ~3% against the Brazilian real since the last earnings call.
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering AptarGroup

1 Month
xxx
Success Rate
10/11 ratings generated profit
91%
Average Return
+4.68%
reiterated a xxx
rating 4 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 90.91% of your transactions generating a profit, with an average return of +4.68% per trade.
3 Months
xxx
Success Rate
10/11 ratings generated profit
91%
Average Return
+9.33%
reiterated a xxx
rating 4 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 90.91% of your transactions generating a profit, with an average return of +9.33% per trade.
1 Year
Gabrial HajdeWells Fargo
Success Rate
20/24 ratings generated profit
83%
Average Return
+12.99%
reiterated a buy rating last month
Copying Gabrial Hajde's trades and holding each position for 1 Year would result in 83.33% of your transactions generating a profit, with an average return of +12.99% per trade.
2 Years
xxx
Success Rate
10/11 ratings generated profit
91%
Average Return
+16.91%
reiterated a xxx
rating 4 months ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 90.91% of your transactions generating a profit, with an average return of +16.91% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

ATR Analyst Recommendation Trends

Rating
Oct 24
Jan 25
Feb 25
Apr 25
May 25
Strong Buy
0
0
0
0
0
Buy
14
11
17
10
11
Hold
1
2
2
2
2
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
15
13
19
12
13
In the current month, ATR has received 11 Buy Ratings, 2 Hold Ratings, and 0 Sell Ratings. ATR average Analyst price target in the past 3 months is 172.67.
Each month's total comprises the sum of three months' worth of ratings.

ATR Financial Forecast

ATR Earnings Forecast

Next quarter’s earnings estimate for ATR is $1.59 with a range of $1.57 to $1.61. The previous quarter’s EPS was $1.20. ATR beat its EPS estimate 100.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 58.04% of the time in the same period. In the last calendar year ATR has Outperformed its overall industry.
Next quarter’s earnings estimate for ATR is $1.59 with a range of $1.57 to $1.61. The previous quarter’s EPS was $1.20. ATR beat its EPS estimate 100.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 58.04% of the time in the same period. In the last calendar year ATR has Outperformed its overall industry.

ATR Sales Forecast

Next quarter’s sales forecast for ATR is $954.06M with a range of $941.50M to $961.79M. The previous quarter’s sales results were $887.30M. ATR beat its sales estimates 0.00% of the time in past 12 months, while its overall industry beat sales estimates 47.54% of the time in the same period. In the last calendar year ATR has Preformed in-line its overall industry.
Next quarter’s sales forecast for ATR is $954.06M with a range of $941.50M to $961.79M. The previous quarter’s sales results were $887.30M. ATR beat its sales estimates 0.00% of the time in past 12 months, while its overall industry beat sales estimates 47.54% of the time in the same period. In the last calendar year ATR has Preformed in-line its overall industry.

ATR Stock Forecast FAQ

What is ATR’s average 12-month price target, according to analysts?
Based on analyst ratings, AptarGroup’s 12-month average price target is 172.67.
    What is ATR’s upside potential, based on the analysts’ average price target?
    AptarGroup has 12.63% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is ATR a Buy, Sell or Hold?
          AptarGroup has a consensus rating of Strong Buy which is based on 3 buy ratings, 1 hold ratings and 0 sell ratings.
            What is AptarGroup’s price target?
            The average price target for AptarGroup is 172.67. This is based on 4 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst price target is $175.00 ,the lowest forecast is $170.00. The average price target represents 12.63% Increase from the current price of $153.31.
              What do analysts say about AptarGroup?
              AptarGroup’s analyst rating consensus is a Strong Buy. This is based on the ratings of 4 Wall Streets Analysts.
                How can I buy shares of ATR?
                Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.
                  What am I Missing?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis